Suppr超能文献

[内源性抑郁症的耐药性 第二部分。情感障碍中对抗抑郁药的难治性]

[Drug resistance in endogenous depression Part II. Refractoriness to antidepressants in affective disorders].

作者信息

Puzyński S, Koszewska I, Kalinowski A, Bogdanowicz E, Swiecicki L

机构信息

II Kliniki Psychiatrycznej Instytutu Psychiatrii i Neurologii w Warszawie.

出版信息

Psychiatr Pol. 1994 Jan-Feb;28(1):5-15.

PMID:8190818
Abstract

Among 67 patients admitted for the first time to the hospital drug resistance was evaluated in the further course of disease for at least 3 consecutive depressive phases. It was established that drug resistance occurs (usually as a single episode) in 28% of patients with endogenous depression and it concerns 10% of all depressive phases. The drug resistance is more frequent after the 45th year of life. The incidence of therapeutic failures is 3% during the first depressive phase and goes up in the consecutive phases. The occurrence of drug resistance in the past has no prognostic value for the next phase. There is a certain subgroup of patients, characterized by repetitive drug resistance during several phases. This phenomenon needs further evaluation.

摘要

在首次入院的67例患者中,在疾病的后续过程中,对至少连续3个抑郁期进行了耐药性评估。结果发现,内源性抑郁症患者中有28%出现耐药性(通常为单次发作),占所有抑郁期的10%。45岁以后耐药性更为常见。在第一个抑郁期治疗失败的发生率为3%,在后续阶段会上升。过去出现耐药性对下一阶段没有预后价值。有一个特定的患者亚组,其特征是在几个阶段反复出现耐药性。这种现象需要进一步评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验